Drug burden index score and anticholinergic risk scale as predictors of readmission to the hospital

Consultant Pharmacist

Volumn 29, Issue 3, 2014, Pages 158-168

  Dispennette, Rachel ^a   Elliott, David ^b   Nguyen, Lisa ^c   Richmond, Rebecca ^a  

^a CHARLESTON AREA MEDICAL CENTER   (United States)

^b WEST VIRGINIA UNIVERSITY   (United States)

^c VA NORTH TEXAS HEALTH CARE SYSTEM   (United States)

Author keywords

Anticholinergic; Drug; Drug burden; Elder; Geriatrics; Readmission; Sedating; Vulnerable

Indexed keywords

ALPRAZOLAM; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONIDINE; GABAPENTIN; HYDROCODONE; HYDROXYZINE; OXYCODONE; SEDATIVE AGENT;

AGE DISTRIBUTION; AGED; ANTICHOLINERGIC RISK SCALE; ARTICLE; COHORT ANALYSIS; DOSE CALCULATION; DRUG BURDEN INDEX SCORE; DRUG EXPOSURE; FEMALE; GERIATRIC PATIENT; HOSPITAL ADMISSION; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; NON PROFIT HOSPITAL; POPULATION RISK; PREDICTIVE VALUE; RETROSPECTIVE STUDY; RISK REDUCTION; STAFF NURSE; VERY ELDERLY; VULNERABLE ELDERS SURVEY SCORE; VULNERABLE POPULATION;

ACOVE = ASSESSING CARE OF VULNERABLE ELDERS; ADL = ACTIVITIES OF DAILY LIVING; ANTICHOLINERGIC; ARS = ANTICHOLINERGIC RISK SCALE; DBI = DRUG BURDEN INDEX; DRUG; DRUG BURDEN; ELDER; GERIATRICS; READMISSION; SEDATING; STOPP = SCREENING TOOL FOR OLDER PERSONS OF POTENTIALLY INAPPROPRIATE PRESCRIPTIONS; TDB = TOTAL DRUG BURDEN; VES-13 = VULNERABLE ELDER SURVEY; VIP = VOLUNTEERS INFORMING PATIENTS; VULNERABLE;

AGED; AGED, 80 AND OVER; CHOLINERGIC ANTAGONISTS; HUMANS; HYDROCODONE; HYDROXYZINE; HYPNOTICS AND SEDATIVES; MALE; PATIENT READMISSION; RETROSPECTIVE STUDIES; RISK; VULNERABLE POPULATIONS;

EID: 84895769748     PISSN: 08885109     EISSN: None     Source Type: Journal    
DOI: 10.4140/TCP.n.2014.158     Document Type: Article

References (16)

1. Kumpula EK, Bell JS, Soini H et al. Anticholinergic drug use and mortality among residents of long-term care facilities: a prospective cohort study. J Clin Pharmacol 2011;51:256-63.
2. Gerretsen P, Pollock BG. Drugs with anticholinergic properties: a current perspective on use and safety. Exp Opin Drug Safety 2011;10:751-65.
3. The American Geriatrics Society 2012 Beers Criteria Update Expert Panel (2012). American Geriatrics Society updated Beers criteria for potentially inappropriate medication use in older adults. J Am Geriatr Soc 2012;60:616-31.
4. Gallagher P, O'Mahony D. STOPP (Screening Tool of Older Persons' potentially inappropriate Prescriptions): application to acutely ill elderly patients and comparison with Beers' criteria. Age Ageing 2008;37:673-9.
5. Hilmer SN, Mager DE, Simonsick EM et al. Drug burden index score and functional decline in older people. Am J Med 2009;122:1142-9.
6. Hilmer SN, Mager DE, Simonsick EM et al. Drug burden index to define the functional burden of medications in older people. Arch Intern Med 2007;167:781-7. (Pubitemid 46658335)
7. Gnjidic D, Le Couteur DG, Abernethy DR et al. A pilot randomized clinical trial utilizing the drug burden index to reduce exposure to anticholinergic and sedative medications in older people. Ann Pharmacother 2010;44:1725-32.
8. Wilson NM, Hilmer SN, March LM et al. Associations between drug burden index and falls in older people in residential aged care. J Am Geriatr Soc 2011;59:875-80.
9. Wilson NM, Hilmer SN, March LM et al. Associations between drug burden index and mortality in older people in residential aged care facilities. Drugs Aging 2012;29:157-65.
10. Gnjidic D, Le Couteur DG, Naganathan V et al. Effects of drug burden index on cognitive function in older men. J Clin Psychopharmacol 2012;32:273-7.
11. Lönroos E, Gnjidic D, Hilmer SN et al. Drug burden index and hospitalization among community-dwelling older people. Drugs Aging 2012;29:395-404.
12. Lowry E, Woodman RJ, Soiza RL et al. Drug burden index, physical function, and adverse outcomes in older hospitalized patients. J Clin Pharmacol 2012;52:1584-91.
13. Rudolph JL, Salow MJ, Angelini MC et al. The Anticholinergic Risk Scale and anticholinergic adverse effects in older persons. Arch Intern Med 2008;168:508-13. (Pubitemid 351547214)
14. Wenger NS, Roth CP, Shekelle P, the ACOVE Investigators. Introduction to the assessing care of vulnerable elders-3 quality indicator measurement set. J Am Geriatr Soc 2007;55:247-53.
15. Saliba D, Elliott M, Rubenstein LZ et al. The Vulnerable Elders Survey: a tool for identifying vulnerable older people in the community. J Am Geriatr Soc 2001;49:1691-9. (Pubitemid 34007998)
16. Mangoni A, Van Munster B, Woodman R et al. Measures of anticholinergic drug exposure, serum anticholinergic activity, and allcause postdischarge mortality in older hospitalized patients with hip fractures. Am J Geriatr Psychiatry 2013;8:785-94.